ROOK / CLAIMS REVIEW 005
A purchasing department is not a medical department.
Management has consolidated wellness, radiation readiness and infant defense into one division. This is apparently efficient because none of the three departments had supplied an outcome study. They have supplied a new letterhead. The letterhead has a copper border.
I asked who signs the medical claims. Procurement said the same person who signs the purchase orders. I asked what qualifies that person. Procurement said the signature was notarized.
Here is the boundary the new division keeps stepping over: a physical property, a narrow medical use and a safe product design are different claims. Evidence for one does not establish the others. The catalog has not supplied clinical studies, approved medical labeling or infant-product safety validation for these concepts. A subscription is not a substitute for any of them.
Different claims need different evidence
OPEN FULL-SIZE BENCH SKETCH ↗The following is a review of those claim boundaries and the cited sources. It is not a treatment recommendation, a radiation-response plan or an instruction to modify a crib. My department has enough trouble keeping Finance away from the power supply.
F08 / More bracelets does not mean more medicine.
The copper garment converts a collection of wellness bracelets into a full-body procurement decision. Sales measures the result in Equivalent Bracelet Units. The unit is beautifully scalable because nobody has defined a corresponding clinical endpoint.
NCCIH distinguishes static magnets from electrically driven magnetic therapies. Its review does not find conclusive support for static magnets as pain treatment. Certain medical electromagnetic treatments have evidence and specific approved uses; a permanent magnet sewn into clothing does not acquire those uses by sharing the word “magnetic.”
A randomized, blinded crossover trial involving 70 people with rheumatoid arthritis found no meaningful therapeutic advantage for the tested copper bracelet or magnetic wrist strap beyond placebo. That trial did not test this garment, every diagnosis or every magnetic therapy. It does undermine the decision to treat bracelet count as a medical specification.
Management proposed doubling the bracelet count. I proposed a controlled study. Management preferred the proposal that could fit on an invoice.
Magnets can interfere with some medical devices, and loose magnets must be kept away from children. Do not use a wearable magnet claim to delay medical care. Those are safety limits in the NCCIH guidance, not optional upgrades. Product and medical qualifications *
C07 / Your thyroid is not your entire body.
The Radiation Readiness Division would like “iodine” to mean “permission to ignore the rest of a radiation emergency.” It has printed that conclusion before identifying the substance, approved medicine or circumstances involved. Its emergency plan currently begins with an unmarked bottle and ends with a reassuring font.
CDC explains that potassium iodide, or KI, can help protect the thyroid from internal radioactive iodine in specific circumstances. It does not protect the rest of the body or other radioactive materials, and cannot reverse damage already done. A generic iodine supplement, table salt or an undefined “blend” is not an equivalent substitute.
CDC says to take KI only when directed by public-health or emergency officials or a healthcare provider, and to use FDA-approved products. This note supplies no dose or individual eligibility decision. The right response depends on the event and the person; it cannot be assigned by the department that classified radioactive fallout as a premium weather package.
An EMP is an electrical-effects problem. Blast, heat, external radiation and contamination introduce other problems. Buying something for one does not establish protection from the others. Sales calls this a bundle opportunity. Engineering calls it a reason to read the actual emergency guidance.
O02 / A crib is not an equipment enclosure.
Someone has proposed putting the baby inside the RF problem. I have returned the proposal with the words “the baby is not a test instrument.” Management has asked whether the test instrument could be sold separately.
Even a material measurement showing radio-frequency attenuation would not establish that an infant enclosure is safe. It would not answer the airflow, entanglement, loose-fabric, attachment, temperature or sleep-environment questions. The catalog supplies neither an infant-safety validation nor a validated RF test for this concept.
NICHD’s safe-sleep guidance calls for a firm, flat, level surface covered only by a fitted sheet. Loose bedding and other items introduce risks. CPSC likewise recommends an appropriate infant sleep product, placing babies on their backs, and a bare sleep space. A shielding theme does not override those requirements.
Do not add a canopy, draped cloth or an improvised enclosure to an infant’s sleep space on the strength of this catalog. Strollers and seated devices are also not substitutes for a regular safe sleep surface. Real product instructions, recalls and qualified pediatric guidance belong ahead of the accessory budget.
Finance says removing the extra fabric reduces the perceived value. I said we are discussing the child’s safety. Finance requested a meeting to align on what “value” means. I declined it.
C04 / A color change is not a toxin analysis.
The foot bath’s chromatic indicator has produced a color. Procurement has promoted the color to a lab result. The lab result has been asked which substance was removed, from where, and by how much. It has declined to specify.
A visible change is an observation. Establishing removal of a particular substance would require identifying it and demonstrating the relevant change with an appropriate comparison. This catalog supplies no such measurements. I have not tested the bath; I am identifying the evidence the claim would need. Health and product qualifications *
The sources have inconveniently narrow conclusions.
Primary research and official guidance below were checked on October 14, 2026. The purchasing committee, letterhead and conversations above are Rook’s narrative. None of these sources tested or endorsed WakeUp’s products.
- NCCIH: Magnets For Pain / evidence distinctions and safety limits.
- Richmond and colleagues, PLOS ONE, 2013 / copper bracelets and magnetic wrist straps in rheumatoid arthritis.
- CDC: Potassium Iodide / a specific use with substantial limitations.
- NICHD: Safe Sleep Environment / the actual requirements before accessories.
- CPSC: Safe Sleep / infant-product and sleep-space guidance.
My suggested procurement order is evidence, qualified guidance, then equipment. Management has appealed the order because none of the first two items qualify for its preferred markup.